Fiscal Year End Company Status Exempt Flag June 30 Delist N Incorporation Locations Inc. Date Expiry Date Country Region Description 5/Sep/1997  2/Oct/2013  Canada  British Columbia    Exchange Filing Office Location (not available)		Business Type(s) Primary/Secondary Business Type Details Primary  *Biotechnology Research &/or Development  InNexus is a drug development company commercializing the next generation of monoclonal antibodies based on its Dynamic Cross Linking technology (DXL) improving potency of existing antibody products while opening new markets and disease applications. DXL antibodies utilize unique, novel and patented methods and technologies of InNexus. InNexus is headquartered in British Columbia with principal management based in Scottsdale, Arizona on the campus of The Mayo Clinic and has its own in-house developmental facilities. These development facilities provide validation of protein and peptide discoveries, enabling InNexus ( and its strategic partners) to advance novel drug therapeutics and diagnostics. To learn more about InNexus, please visit www.innexusbiotech.com.    *Mineral Exploration/Development  (not available)    *Change of Business/Reverse Takeover under review  Gold and Silver mine, Acquisition of Public Media Works of Delaware, under review.    *Gold And Silver Mining  (not available)  Secondary  *Oil & Gas Extraction  (not available)    *Oil & Gas Exploration  (not available)  Securities Symbol Security Name Market Status *IXS.H *InNexus Biotechnology Inc. TSX Venture DELIST *IXS *InNexus Biotechnology Inc. TSX Venture DELIST *CUS *Cusil Venture Corporation TSX Venture DELIST *CUS *Cusil Venture Corporation VSE DELIST Name History From To *InNexus Biotechnology Inc. 3/Jul/2003 2/Oct/2013 *Cusil Venture Corporation 5/Sep/1997 2/Jul/2003 Company Facts Reconciliation Subject Date Returned Summer 2013 CFR 29/Jul/2013 Associations Auditing Firm:  *Hein & Associates, LLP, CPA   *KPMG LLP   *G. Ross McDonald, CA Investor Relations:  *The Investor Relations Group Ltd. Law Firm:  *Leschert & Company Law Corporation   *Greg Yanke Law Corp.   *Heenan Blaikie Subsidiary:  *Innexus Inc.   *Innexus Biotechnology International Ltd.   *Innexus Exchange Corp.   *North BioScience Inc.   *Innexus Bioscience (Barbados) Inc. Transfer Agent:  *Computershare Trust Company of Canada
Latest Information Type Date Title News Releases  7/Nov/2011  NEWS RELEASE - BCSC CEASE TRADE ORDER FOR ALDA PHARMACEUTICALS[MARKET NEWS]     NEWS RELEASE - INNEXUS APPOINTS CHIEF FINANCIAL OFFICER[BUSINESS WIRE]     NEWS RELEASE - INNEXUS GRANTS INCENTIVE STOCK OPTIONS[BUSINESS WIRE] Bulletins  1/Oct/2013  Listing Maintenance Fees - Delist Meetings and Public Filings    Information on financial statements, public filings and corporate meetings for all Canadian public companies can be found at www.sedar.com
Property Locations Location Name: *Gord S Property  Area Name: *Nicola Mining Division  Effective Date: 22/Jun/2000  Location Ownership Percent: 100  Expiry Date: 21/Sep/2004  Phone: (not available) Address: British Columbia Canada North America Fax: (not available) Description:   Location Name: *Knobhill Area  Area Name: *Knobhill Area  Effective Date: 22/Nov/1999  Location Ownership Percent: 5  Expiry Date: 31/Dec/2002  Phone: (not available) Address: Alberta Canada North America Fax: (not available) Description:   Location Name: *Merico Ethel Property  Area Name: *James and Tudehope Townships  Effective Date: 1/Oct/1997  Location Ownership Percent: 100  Expiry Date: 1/Jun/1999  Phone: (not available) Address: Ontario Canada North America Fax: (not available) Description: option to acquire, and subject to a 3% NSR  Location Name: *Silver Fox Property  Area Name: *  Effective Date: 6/Jul/1998  Location Ownership Percent: 100  Expiry Date: 1/Feb/1999  Phone: (not available) Address: Ontario Canada North America Fax: (not available) Description: option to acquire, subject to a 2.5% NSR

* Historical Data